Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Bendza Gary MarkEVP, CFO | Tax withholding | F | $211K 49.5K sh | Mar 20, 2026 |
| 12 | Duffy Kristine DDirector | Other acquisition or disposition | J | $7,495 236 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Antonello Katherine H.Director, President & CEO | Tax withholding | F | $205K 5,258 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Boone Travis JDirector, PRESIDENT & CEO | Tax withholding | F | $109K 10.5K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 12 | Robbins Edward Hutchinson Jr.EVP, General Counsel | Tax withholding | F | $216K 50.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 12 | Stenberg JonDirector, President & CEO | Tax withholding | F | $55K 11.9K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Morris Philip CDirector | Other acquisition or disposition | J | $7,495 236 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Herraiz Lizette BenediGENERAL COUNSEL | Open-market sale · 10b5-1 plan | SELL | $238K 2,982 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Dawsey James MDirector | Other acquisition or disposition | J | $14K 453 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 11 | Dieter DavidEVP & General Counsel | Open-market sale · 10b5-1 plan | SELL | $488K 14.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | You Harry L.Director, 10% Owner | Grant or award | A | — 1.16M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Gessert EricaChief Financial Officer | Option exercise | M | — 8,433 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 543.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Champlin Christopher CraigSenior Vice President, Sales | Tax withholding | F | $12K 306 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Nixon D. GailSenior VP, Human Resources | Tax withholding | F | $1,849 1,249 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 30.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | dMY Squared Sponsor, LLCDirector, 10% Owner | Derivative conversion | C | — 1.16M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | dMY Squared Sponsor, LLCDirector, 10% Owner | Derivative conversion | C | — 1.16M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 211.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Shlimak AnnaSee Remarks | Tax withholding | F | $25K 9,767 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 162.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 211.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Marcus Andrew T.See Remarks | Grant or award | A | — 14.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Mutschink John M.EVP, Chief Admin Officer | Tax withholding | F | $25K 635 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Brown HaydenDirector, President & CEO | Option exercise | M | — 17.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 40.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 60.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Disposition to issuer | D | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |